Dynatronics Corporation (DYNT)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -976 Thousand USD | 72.14% |
| 2023 | -3.5 Million USD | -0.89% |
| 2022 | -3.33 Million USD | -52.28% |
| 2021 | -2.28 Million USD | 23.82% |
| 2020 | -1.26 Million USD | -276.01% |
| 2019 | 1.15 Million USD | -1273.73% |
| 2018 | 67.81 Thousand USD | 105.07% |
| 2017 | -1.08 Million USD | 3.16% |
| 2016 | -1.16 Million USD | -101.05% |
| 2015 | -621.43 Thousand USD | -273.69% |
| 2014 | 364.24 Thousand USD | -40.05% |
| 2013 | 683.27 Thousand USD | 34.09% |
| 2012 | 520.76 Thousand USD | -56.88% |
| 2011 | 1.16 Million USD | -22.59% |
| 2010 | 1.5 Million USD | 26.11% |
| 2009 | 1.14 Million USD | 152.21% |
| 2008 | -8.82 Million USD | -1126.22% |
| 2007 | 250.52 Thousand USD | -63.17% |
| 2006 | 657.56 Thousand USD | -62.89% |
| 2005 | 1.62 Million USD | -13.5% |
| 2004 | 1.85 Million USD | 223.01% |
| 2003 | 582.2 Thousand USD | -51.9% |
| 2002 | 1.2 Million USD | -1.75% |
| 2001 | 1.23 Million USD | 36.54% |
| 2000 | 919.12 Thousand USD | -50.85% |
| 1999 | 1.9 Million USD | 38.46% |
| 1998 | 1.4 Million USD | 225.0% |
| 1997 | 900 Thousand USD | -55.56% |
| 1996 | 400 Thousand USD | 200.0% |
| 1995 | 500 Thousand USD | 133.33% |
| 1994 | -400 Thousand USD | -1000.0% |
| 1993 | 300 Thousand USD | -88.89% |
| 1992 | 800 Thousand USD | 80.0% |
| 1991 | 500 Thousand USD | -28.57% |
| 1990 | 700 Thousand USD | -22.22% |
| 1989 | 900 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -240 Thousand USD | 104.01% |
| 2024 Q3 | -239.7 Thousand USD | 57.99% |
| 2024 Q4 | -559 Thousand USD | -2.89% |
| 2024 Q2 | -570.54 Thousand USD | -805.57% |
| 2023 Q1 | -131.25 Thousand USD | 88.9% |
| 2023 FY | - USD | -0.89% |
| 2023 Q2 | -460.25 Thousand USD | -250.65% |
| 2023 Q3 | -1.22 Million USD | -165.51% |
| 2023 Q4 | -2.01 Million USD | -64.89% |
| 2022 FY | - USD | -52.28% |
| 2022 Q1 | 881.14 Thousand USD | 147.58% |
| 2022 Q2 | -1.04 Million USD | -218.31% |
| 2022 Q3 | -1.08 Million USD | -3.6% |
| 2022 Q4 | -1.18 Million USD | -9.44% |
| 2021 FY | - USD | 23.82% |
| 2021 Q1 | 87.68 Thousand USD | 103.94% |
| 2021 Q2 | -224.28 Thousand USD | -355.78% |
| 2021 Q3 | 586.41 Thousand USD | 361.46% |
| 2021 Q4 | -1.85 Million USD | -415.82% |
| 2020 Q3 | -531.8 Thousand USD | -1561.9% |
| 2020 Q1 | 657.81 Thousand USD | 292.91% |
| 2020 Q2 | -32 Thousand USD | -104.86% |
| 2020 FY | - USD | -276.01% |
| 2020 Q4 | -2.22 Million USD | -318.76% |
| 2019 Q3 | -413 Thousand USD | -235.18% |
| 2019 Q4 | -341 Thousand USD | 17.43% |
| 2019 FY | - USD | -1273.73% |
| 2019 Q1 | 816.3 Thousand USD | 832.16% |
| 2019 Q2 | 305.52 Thousand USD | -62.57% |
| 2018 Q3 | -692.98 Thousand USD | -255.25% |
| 2018 Q4 | -111.49 Thousand USD | 83.91% |
| 2018 FY | - USD | 105.07% |
| 2018 Q1 | 403.94 Thousand USD | 180.18% |
| 2018 Q2 | 446.35 Thousand USD | 10.5% |
| 2017 FY | - USD | 3.16% |
| 2017 Q4 | -503.78 Thousand USD | 25.75% |
| 2017 Q3 | -678.48 Thousand USD | -3415.33% |
| 2017 Q1 | -174.55 Thousand USD | 83.77% |
| 2017 Q2 | 20.46 Thousand USD | 111.72% |
| 2016 FY | - USD | -101.05% |
| 2016 Q4 | -1.07 Million USD | -255.31% |
| 2016 Q3 | -302.69 Thousand USD | -1040.81% |
| 2016 Q2 | 32.17 Thousand USD | 194.75% |
| 2016 Q1 | -33.95 Thousand USD | 95.61% |
| 2015 Q3 | -87.42 Thousand USD | -141.4% |
| 2015 FY | - USD | -273.69% |
| 2015 Q1 | 257.27 Thousand USD | 66.44% |
| 2015 Q2 | 211.15 Thousand USD | -17.92% |
| 2015 Q4 | -772.79 Thousand USD | -783.96% |
| 2014 Q3 | -25.49 Thousand USD | -110.74% |
| 2014 FY | - USD | -40.05% |
| 2014 Q4 | 154.57 Thousand USD | 706.35% |
| 2014 Q1 | 28.68 Thousand USD | -46.11% |
| 2014 Q2 | 237.39 Thousand USD | 727.58% |
| 2013 FY | - USD | 34.09% |
| 2013 Q4 | 53.23 Thousand USD | -48.97% |
| 2013 Q3 | 104.31 Thousand USD | -73.62% |
| 2013 Q2 | 395.45 Thousand USD | 272.6% |
| 2013 Q1 | 106.13 Thousand USD | -59.48% |
| 2012 Q3 | -72.84 Thousand USD | -130.31% |
| 2012 Q4 | 261.94 Thousand USD | 459.61% |
| 2012 FY | - USD | -56.88% |
| 2012 Q1 | 62.1 Thousand USD | -76.71% |
| 2012 Q2 | 240.35 Thousand USD | 287.05% |
| 2011 Q1 | 207.13 Thousand USD | -21.44% |
| 2011 Q2 | 293.52 Thousand USD | 41.71% |
| 2011 Q4 | 266.61 Thousand USD | -28.46% |
| 2011 Q3 | 372.7 Thousand USD | 26.98% |
| 2011 FY | - USD | -22.59% |
| 2010 Q1 | 345.46 Thousand USD | 12.04% |
| 2010 Q3 | 341.59 Thousand USD | -34.55% |
| 2010 Q4 | 263.66 Thousand USD | -22.81% |
| 2010 Q2 | 521.9 Thousand USD | 51.07% |
| 2010 FY | - USD | 26.11% |
| 2009 Q3 | 457.42 Thousand USD | 40.79% |
| 2009 Q1 | 64.74 Thousand USD | 117.54% |
| 2009 Q2 | 324.9 Thousand USD | 401.86% |
| 2009 FY | - USD | 152.21% |
| 2009 Q4 | 308.35 Thousand USD | -32.59% |
| 2008 Q1 | -875.28 Thousand USD | -380.65% |
| 2008 Q2 | -250.15 Thousand USD | 71.42% |
| 2008 Q3 | -742.21 Thousand USD | -196.7% |
| 2008 Q4 | -369.09 Thousand USD | 50.27% |
| 2008 FY | - USD | -1126.22% |
| 2007 FY | - USD | -63.17% |
| 2007 Q3 | 2773.00 USD | -95.54% |
| 2007 Q1 | -158.82 Thousand USD | -242.92% |
| 2007 Q2 | 62.13 Thousand USD | 139.12% |
| 2007 Q4 | 311.87 Thousand USD | 11146.84% |
| 2006 FY | - USD | -62.89% |
| 2006 Q4 | 111.12 Thousand USD | -19.71% |
| 2006 Q3 | 138.39 Thousand USD | -63.89% |
| 2006 Q2 | 383.28 Thousand USD | 1034.36% |
| 2006 Q1 | -41.02 Thousand USD | -111.97% |
| 2005 Q4 | 342.6 Thousand USD | -8.5% |
| 2005 Q3 | 374.41 Thousand USD | -28.93% |
| 2005 FY | - USD | -13.5% |
| 2005 Q1 | 350.94 Thousand USD | -20.16% |
| 2005 Q2 | 526.8 Thousand USD | 50.11% |
| 2004 Q4 | 439.55 Thousand USD | -11.37% |
| 2004 Q2 | 532.01 Thousand USD | 41.4% |
| 2004 Q3 | 495.94 Thousand USD | -6.78% |
| 2004 FY | - USD | 223.01% |
| 2004 Q1 | 376.24 Thousand USD | 440.14% |
| 2003 FY | - USD | -51.9% |
| 2003 Q2 | 216.37 Thousand USD | -26.59% |
| 2003 Q1 | 295.04 Thousand USD | -3.6% |
| 2003 Q4 | -104.62 Thousand USD | -163.35% |
| 2003 Q3 | 175.4 Thousand USD | -18.62% |
| 2002 Q3 | 303.82 Thousand USD | 22.94% |
| 2002 FY | - USD | -1.75% |
| 2002 Q4 | 312.55 Thousand USD | 0.19% |
| 2002 Q2 | 248.28 Thousand USD | -26.52% |
| 2002 Q1 | 337.3 Thousand USD | 0.02% |
| 2001 Q2 | 248.4 Thousand USD | -32.56% |
| 2001 Q3 | 270.25 Thousand USD | 8.09% |
| 2001 Q4 | 344.44 Thousand USD | 26.47% |
| 2001 FY | - USD | 36.54% |
| 2001 Q1 | 367.22 Thousand USD | -44.79% |
| 2000 Q2 | - USD | -100.0% |
| 2000 Q3 | 27.07 Thousand USD | 0.0% |
| 2000 FY | - USD | -50.85% |
| 2000 Q1 | 300 Thousand USD | 0.0% |
| 2000 Q4 | 667.72 Thousand USD | 4923.01% |
| 1999 Q2 | 300 Thousand USD | -62.5% |
| 1999 Q4 | 300 Thousand USD | -25.0% |
| 1999 FY | - USD | 38.46% |
| 1999 Q1 | 800 Thousand USD | 166.67% |
| 1999 Q3 | 400 Thousand USD | 33.33% |
| 1998 Q3 | 300 Thousand USD | 50.0% |
| 1998 FY | - USD | 225.0% |
| 1998 Q1 | 300 Thousand USD | -25.0% |
| 1998 Q2 | 200 Thousand USD | -33.33% |
| 1998 Q4 | 300 Thousand USD | 0.0% |
| 1997 Q4 | 200 Thousand USD | -20.0% |
| 1997 Q3 | 300 Thousand USD | 400.0% |
| 1997 Q1 | 300 Thousand USD | 200.0% |
| 1997 Q2 | 100 Thousand USD | -66.67% |
| 1997 FY | - USD | -55.56% |
| 1996 FY | - USD | 200.0% |
| 1996 Q4 | -200 Thousand USD | -400.0% |
| 1996 Q3 | 100 Thousand USD | -80.0% |
| 1996 Q2 | 300 Thousand USD | 600.0% |
| 1996 Q1 | -100 Thousand USD | 0.0% |
| 1995 FY | - USD | 133.33% |
| 1995 Q3 | 200 Thousand USD | 0.0% |
| 1995 Q2 | 300 Thousand USD | 100.0% |
| 1995 Q1 | 100 Thousand USD | 133.33% |
| 1995 Q4 | - USD | -150.0% |
| 1994 Q2 | 200 Thousand USD | 125.0% |
| 1994 Q1 | -800 Thousand USD | -900.0% |
| 1994 FY | - USD | -1000.0% |
| 1994 Q4 | -200 Thousand USD | -400.0% |
| 1994 Q3 | 100 Thousand USD | -50.0% |
| 1993 Q4 | 100 Thousand USD | -50.0% |
| 1993 Q1 | 100 Thousand USD | -66.67% |
| 1993 FY | - USD | -88.89% |
| 1993 Q2 | - USD | -100.0% |
| 1993 Q3 | 200 Thousand USD | 0.0% |
| 1992 Q3 | 200 Thousand USD | 0.0% |
| 1992 Q2 | 200 Thousand USD | 0.0% |
| 1992 Q1 | 200 Thousand USD | 0.0% |
| 1992 Q4 | 100 Thousand USD | 50.0% |
| 1992 FY | - USD | 80.0% |
| 1991 Q2 | 100 Thousand USD | -50.0% |
| 1991 Q1 | 200 Thousand USD | 100.0% |
| 1991 Q4 | 200 Thousand USD | 0.0% |
| 1991 Q3 | 200 Thousand USD | 100.0% |
| 1991 FY | - USD | -16.67% |
| 1990 Q2 | 1.6 Million USD | 6.67% |
| 1990 Q4 | 100 Thousand USD | -50.0% |
| 1990 FY | - USD | -33.33% |
| 1990 Q1 | 1.5 Million USD | 134.09% |
| 1990 Q3 | 200 Thousand USD | -87.5% |
| 1989 Q1 | 1.5 Million USD | 0.0% |
| 1989 Q2 | 1.8 Million USD | 20.0% |
| 1989 FY | - USD | 0.0% |
| 1989 Q4 | -4.4 Million USD | -309.52% |
| 1989 Q3 | 2.1 Million USD | 16.67% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 92.763% |
| Cerus Corporation | -26.53 Million USD | 96.322% |
| OrthoPediatrics Corp. | -8.38 Million USD | 88.355% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 90.7% |
| Talis Biomedical Corporation | -66.04 Million USD | 98.522% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 94.147% |
| Inogen, Inc. | -45.67 Million USD | 97.863% |
| Spectral AI, Inc. | -12.26 Million USD | 92.04% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 97.954% |
| CVRx, Inc. | -38.73 Million USD | 97.48% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 72.335% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 91.938% |
| Orthofix Medical Inc. | -86.98 Million USD | 98.878% |
| Venus Concept Inc. | -26.11 Million USD | 96.262% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 98.039% |
| Bioventus Inc. | -23.07 Million USD | 95.769% |
| BrainsWay Ltd. | -2.31 Million USD | 57.767% |
| Envoy Medical, Inc. | -18.23 Million USD | 94.648% |
| electroCore, Inc. | -17.76 Million USD | 94.504% |
| IceCure Medical Ltd | -15.25 Million USD | 93.601% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 98.038% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 94.21% |
| MaxCyte, Inc. | -44.12 Million USD | 97.788% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 91.698% |
| Nexalin Technology, Inc. | -5.69 Million USD | 82.853% |
| PAVmed Inc | -75.74 Million USD | 98.711% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 98.184% |
| RxSight, Inc. | -41.03 Million USD | 97.622% |
| Sight Sciences, Inc. | -49.41 Million USD | 98.025% |
| SI-BONE, Inc. | -34.44 Million USD | 97.167% |
| TELA Bio, Inc. | -40.63 Million USD | 97.598% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 98.326% |
| Treace Medical Concepts, Inc. | -39 Million USD | 97.498% |
| LivaNova PLC | 39.01 Million USD | 102.502% |
| 908 Devices Inc. | -34.02 Million USD | 97.131% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 99.117% |
| Nemaura Medical Inc. | -7.28 Million USD | 86.606% |
| NeuroPace, Inc. | -22.83 Million USD | 95.726% |
| LENSAR, Inc. | -8.71 Million USD | 88.8% |
| Apyx Medical Corporation | -18.11 Million USD | 94.611% |
| Cutera, Inc. | -136.56 Million USD | 99.285% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 71.124% |
| BioSig Technologies, Inc. | -28.15 Million USD | 96.533% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 138.792% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 95.35% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 100.254% |
| Axonics, Inc. | 7.77 Million USD | 112.553% |
| Outset Medical, Inc. | -153.78 Million USD | 99.365% |
| IRIDEX Corporation | -7.44 Million USD | 86.896% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 99.005% |
| IRadimed Corporation | 20.8 Million USD | 104.692% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 87.894% |
| INVO Bioscience, Inc. | -6.88 Million USD | 85.814% |
| Telesis Bio, Inc. | -40.49 Million USD | 97.59% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 102.661% |
| Varex Imaging Corporation | 67.2 Million USD | 101.452% |
| Quipt Home Medical Corp. | 44.07 Million USD | 102.215% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 91.021% |
| Pulmonx Corporation | -55.09 Million USD | 98.228% |
| Modular Medical, Inc. | -17.1 Million USD | 94.293% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 93.262% |
| Semler Scientific, Inc. | 23.58 Million USD | 104.138% |
| InMode Ltd. | 196.28 Million USD | 100.497% |
| Bruker Corporation | 599 Million USD | 100.163% |
| Cytosorbents Corporation | -28.81 Million USD | 96.612% |
| DexCom, Inc. | 916.7 Million USD | 100.106% |
| Align Technology, Inc. | 799.03 Million USD | 100.122% |
| Viveve Medical, Inc. | -20.61 Million USD | 95.266% |
| ZimVie Inc. | 91.07 Million USD | 101.072% |
| Movano Inc. | -29.12 Million USD | 96.649% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 77.858% |
| Nexalin Technology, Inc. | -5.69 Million USD | 82.853% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 72.335% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 99.499% |
| Profound Medical Corp. | -27.12 Million USD | 96.402% |
| Insulet Corporation | 323.6 Million USD | 100.302% |
| enVVeno Medical Corporation | -25.01 Million USD | 96.099% |
| Surmodics, Inc. | 1.18 Million USD | 182.156% |
| iCAD, Inc. | -6.56 Million USD | 85.133% |
| Nuwellis, Inc. | -16.35 Million USD | 94.033% |
| Biotricity, Inc. | -8.82 Million USD | 88.945% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 98.992% |
| Aethlon Medical, Inc. | -11.84 Million USD | 91.763% |
| InspireMD, Inc. | -20.91 Million USD | 95.333% |
| PAVmed Inc. | -75.74 Million USD | 98.711% |
| BIOLASE, Inc. | -15.13 Million USD | 93.553% |
| Beyond Air, Inc. | -59.03 Million USD | 98.347% |
| FONAR Corporation | 28.25 Million USD | 103.455% |
| AxoGen, Inc. | -13.32 Million USD | 92.677% |
| Vivani Medical, Inc. | -26.6 Million USD | 96.332% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 103.977% |
| Inari Medical, Inc. | 7.11 Million USD | 113.721% |
| UFP Technologies, Inc. | 72.74 Million USD | 101.342% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 71.173% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 84.145% |
| Tenon Medical, Inc. | -15.52 Million USD | 93.715% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 93.607% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 97.647% |
| AdaptHealth Corp. | -171.09 Million USD | 99.43% |
| Sintx Technologies, Inc. | -6.6 Million USD | 85.212% |
| NanoVibronix, Inc. | -3.43 Million USD | 71.586% |
| Quanterix Corporation | -38.08 Million USD | 97.437% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 91.021% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 3353.36% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 99.648% |
| TransMedics Group, Inc. | -7.6 Million USD | 87.163% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 95.516% |
| NeuroMetrix, Inc. | -7.09 Million USD | 86.245% |
| Hyperfine, Inc. | -47.06 Million USD | 97.926% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 98.326% |
| Biomerica, Inc. | -5.99 Million USD | 83.714% |
| Bone Biologics Corporation | 479.57 Thousand USD | 303.516% |
| AVITA Medical, Inc. | -39.56 Million USD | 97.533% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 89.36% |
| Silk Road Medical, Inc | -45.08 Million USD | 97.835% |